Author | Peter Voorhees, MD

Articles

Peter Voorhees, MD, Discusses Results from the Ongoing GRIFFIN Study

February 18, 2020

The study is evaluating daratumumab plus lenalidomide, bortezomib, and dexamethasone in autologous stem cell transplant eligible patients newly diagnosed with multiple myeloma.